The possibility of using gastroenteroprotector rebamipide to improve the antithrombotic therapy safety

The possibility of using gastroenteroprotector rebamipide to improve the antithrombotic therapy safety

Antithrombotic drugs (antiplatelet agents and anticoagulants) are widely used in cardiological practice for primary and secondary prevention of thrombotic/thromboembolic complications, however, the use of such drugs is associated with the increased risk of hemorrhagic complications, including gastro...

Full description

Bibliographic Details
Main Authors: Natalya M. Vorobyeva, Irina P. Malaya, Vadim D. Zakiev, Olga N. Tkacheva
Format: Article
Language:English
Published: LLC "MEDIAFORMAT" 2023-06-01
Series:Клинический разбор в общей медицине
Subjects:
antiplatelet agents
anticoagulants
gastrointestinal hemorrhage
increased epithelial permeability syndrome
gastroenteroprotector
rebamipide
proton pump inhibitor
Online Access:https://klin-razbor.ru/en/archive/2023/vol-4-6-2023/the-possibility-of-using-gastroenteroprotector-rebamipide-to-improve-the-antithrombotic-therapy-safe_6496/?element

Internet

https://klin-razbor.ru/en/archive/2023/vol-4-6-2023/the-possibility-of-using-gastroenteroprotector-rebamipide-to-improve-the-antithrombotic-therapy-safe_6496/?element

Similar Items